CoChat

Meta‐Analysis of Natural Therapies for Hyperlipidemia: Plant Sterols and Stanols versus Policosanol

Chen, Judy T., Wesley, Robert, Shamburek, Robert D., Pucino, Frank, Csako, Gyorgy · 2005 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Cited by 129

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Study Objective. To compare the efficacy and safety of plant sterols and stanols as well as policosanol in the treatment of coronary heart disease, as measured by a reduction in low‐density lipoprotein cholesterol (LDL) levels. Design. Systematic review and meta‐analysis of randomized controlled trials. Patients. A total of 4596 patients from 52 eligible studies. Measurements and Main Results. We searched MEDLINE, EMBASE, the Web of Science, and the Cochrane Library from January 1967–June 2003 to identify pertinent studies. Reduction of LDL levels was the primary end point; effects on other lipid parameters and withdrawal of study patients due to adverse effects were the secondary end points. Weighted estimates of percent change in LDL were −11.0% for plant sterol and stanol esters 3.4 g/day (range 2–9 g/day [893 patients]) versus −2.3% for placebo (769 patients) in 23 eligible studies, compared with −23.7% for policosanol 12 mg/day (range 5–40 mg/day [1528 patients]) versus −0.11% for placebo (1406 patients) in 29 eligible studies. Cumulative p values were significantly different from placebo for both (p<0.0001). The net LDL reduction in the treatment groups minus that in the placebo groups was greater with policosanol than plant sterols and stanols (−24% versus −10%, p<0.0001). Policosanol also affected total cholesterol, high‐density lipoprotein cholesterol (HDL), and triglyceride levels more favorably than plant sterols and stanols. Policosanol caused a clinically significant decrease in the LDL:HDL ratio. Pooled withdrawal rate due to adverse effects and combined relative risk for patients who withdrew were 0% and 0.84, respectively (95% confidence interval [CI] 0.36–1.95, p=0.69), for plant sterols and stanols across 20 studies versus 0.86% and 0.31, respectively (95% CI 0.20–0.48, p<0.0001), for policosanol across 28 studies. Conclusion. Plant sterols and stanols and policosanol are well tolerated and safe; however, policosanol is more effective than plant sterols and stanols for LDL level reduction and more favorably alters the lipid profile, approaching antilipemic drug efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1592/phco.25.2.171.56942

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 129

Metadata

Authors
Chen, J. T., Wesley, R., Shamburek, R. D., Pucino, F., & Csako, G.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
2005-02
Volume
25
Issue
2
Pages
171-183
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2043042777
Cited by
129
References
6
FWCI
9.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta‐Analysis of Natural Therapies for Hyperlipidemia: Plant Sterols and Stanols versus Policosanol. https://app.cochat.ai/papers/10.1592/phco.25.2.171.56942
The paper
Chen, J. T., Wesley, R., Shamburek, R. D., Pucino, F., & Csako, G. (2005). Meta‐Analysis of Natural Therapies for Hyperlipidemia: Plant Sterols and Stanols versus Policosanol. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1592/phco.25.2.171.56942

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.